Achilles Therapeutics plc ACHL
Set alert
1.48 0.00 0.00%
At close · Mar 20
1.48 Day range 1.48
52-week range unavailable
- YTD
- +29.82%
- 1 year
- +14.73%
- Open
- 1.48
- Prev close
- 1.48
- Mkt cap
- 48.70M
- Vol
- 1.20M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.48
- High
- 1.48
- Forward P/E
- -0.61
- Beta
- 1.34
- Short ratio
- 1.69
- Inst. own
- 59.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 1.02
- 200-d avg
- 0.91881
- 1y target
- 0.00
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.46 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.30 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | -1.74 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Apr 5, 2024 | Piper Sandler | Downgrade | Overweight | Neutral |
| Dec 14, 2023 | B of A Securities | Downgrade | Buy | Underperform |
| Aug 7, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 11, 2023 | Chardan Capital | Maintained | Buy | Buy |
| Dec 7, 2022 | Chardan Capital | Maintained | — | Buy |
| Dec 7, 2022 | Piper Sandler | Maintained | — | Overweight |
| Apr 26, 2021 | JP Morgan | Initiated | — | Underweight |
| Apr 26, 2021 | B of A Securities | Initiated | — | Buy |
| Apr 26, 2021 | Chardan Capital | Initiated | — | Buy |
| Apr 26, 2021 | Piper Sandler | Initiated | — | Overweight |
| Apr 26, 2021 | Oppenheimer | Initiated | — | Outperform |
